Should (Prophylactic) Medications Be Used for the Management of Death Rattle?

被引:5
|
作者
van Esch, Harriette Johanna [1 ,2 ,6 ,7 ]
Campbell, Margret L. [3 ]
Mori, Masanori [4 ]
Yamaguchi, Takayashi [5 ]
机构
[1] Erasmus MC, Dept Med Oncol, Canc Inst, Rotterdam, Netherlands
[2] Erasmus MC, Dept Publ Hlth, Canc Inst, Rotterdam, Netherlands
[3] Wayne State Univ, Coll Nursing, Detroit, MI USA
[4] Seirei Mikatahara Gen Hosp, Dept Palliat & Support Care, Hamamatsu, Japan
[5] Kobe Univ, Grad Sch Med, Dept Palliat Med, Kobe, Japan
[6] Erasmus MC, Dept Med Oncol, Canc Inst, Dr Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands
[7] Erasmus MC, Dept Publ Hlth, Canc Inst, Dr Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands
关键词
death rattle; randomised controlled trial; opinion; end-of -life care; RESPIRATORY-DISTRESS; SOUND; LIFE;
D O I
10.1016/j.jpainsymman.2023.06.017
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Death rattle is a common symptom in the dying phase and has impact on relatives and health care providers. One controversial topic regarding the management of death rattle in the dying phase is whether the symptom should be treated. In this "Controversies in Palliative Care" article, three expert clinicians independently answer this question. Specifically, each group provides a synopsis of the key studies that inform their thought processes, share practical advice on their clinical approach, and highlight the opportunities for future research. The three experts have different opinions on the assessment of death rattle. This seems to depend on the unknown burden of death rattle on the patient. Explanation of the symptom and reassurance could be sufficient. But considering the known burden on some of the relatives, there might be good reasons to use medication to relieve this symptom. Whether this treatment should be performed preventively or only when death rattle develops remains an matter of debate. Further scientific, clinical, and societal debate on the concept of a "good death" for relatives, the meaning of the symptom death rattle, and the impact of medication is needed. J Pain Symptom Manage 2023;66:e513-e517. (c) 2023 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:E513 / E517
页数:5
相关论文
共 50 条
  • [31] Response to "Hyoscine Butylbromide for the Management of Death Rattle: Sooner Rather Than Later"
    van Esch, Harriette J.
    Geijteman, Eric C. T.
    van der Rijt, Carin C. D.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2019, 57 (04) : E1 - E2
  • [32] Benefits and Risks of Medications Used in the Management of Hypotension: A Review
    Skylynn, Thangwaritorn
    Abel, Thomas
    Christopher, Lee
    Suliman, Ghafary
    Dominic, Rivera
    Joel, Varughese
    Yu, Zeyu
    Pemminati, Sudhakar
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (01)
  • [33] The Effects of Medications Used for the Management of Dyslipidemia on Postprandial Lipemia
    Tentolouris, N.
    Eleftheriadou, I.
    Katsilambros, N.
    CURRENT MEDICINAL CHEMISTRY, 2009, 16 (02) : 203 - 217
  • [34] Effect of Prophylactic Subcutaneous Scopolamine Butylbromide on Death Rattle in Patients at the End of Life The SILENCE Randomized Clinical Trial
    van Esch, Harriette J.
    van Zuylen, Lia
    Geijteman, Eric C. T.
    Oomen-de Hoop, Esther
    Huisman, Bregje A. A.
    Noordzij-Nooteboom, Heike S.
    Boogaard, Renske
    van der Heide, Agnes
    van der Rijt, Carin C. D.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (13): : 1268 - 1276
  • [35] SHOULD PROPHYLACTIC ANTIBIOTICS BE USED IN THE MANAGEMENT OF CEREBROSPINAL-FLUID RHINORRHEA FOLLOWING ENDOSCOPIC SINUS SURGERY - A REVIEW OF THE LITERATURE
    MORALEE, SJ
    CLINICAL OTOLARYNGOLOGY, 1995, 20 (02) : 100 - 102
  • [36] Efficiency of Varroa destructor management with medications used in Poland
    Bak, Beata
    Wilde, Jerzy
    Siuda, Maciej
    MEDYCYNA WETERYNARYJNA-VETERINARY MEDICINE-SCIENCE AND PRACTICE, 2013, 69 (12): : 744 - 748
  • [37] Response to Hyoscine Butylbromide for the Management of Death Rattle: Sooner Rather Than Later
    Mercadante, Sebastiano
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2019, 57 (01) : E15 - E16
  • [38] SHOULD VETERINARIANS PRESCRIBE MEDICATIONS THAT ARE NEITHER THERAPEUTIC NOR PROPHYLACTIC IN ORDER TO INCREASE PRODUCTIVITY IN LIVESTOCK
    SCHENKELS, F
    ROLLIN, BE
    CANADIAN VETERINARY JOURNAL-REVUE VETERINAIRE CANADIENNE, 1995, 36 (09): : 535 - 536
  • [39] Which terms should be used to describe medications used in the treatment of seizure disorders? An ILAE position paper
    Perucca, Emilio
    French, Jacqueline A.
    Aljandeel, Ghaieb
    Balestrini, Simona
    Braga, Patricia
    Burneo, Jorge G.
    Felli, Augustina Charway
    Cross, J. Helen
    Galanopoulou, Aristea S.
    Jain, Satish
    Jiang, Yuwu
    Kaelviaeinen, Reetta
    Lim, Shih Hui
    Meador, Kimford J.
    Mogal, Zarine
    Nabbout, Rima
    Sofia, Francesca
    Somerville, Ernest
    Sperling, Michael R.
    Triki, Chahnez
    Trinka, Eugen
    Walker, Matthew C.
    Wiebe, Samuel
    Wilmshurst, Jo M.
    Wirrell, Elaine
    Yacubian, Elza Marcia
    Kapur, Jaideep
    EPILEPSIA, 2024, 65 (03) : 533 - 541
  • [40] Should prophylactic surgery be used in women with high risk of breast cancer?: Arbiter
    Cortés-Funes, H
    Colomer, R
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (13) : 2158 - 2159